Ilenia Migliaccio
0000-0001-9055-4522
Publication & Citation Trends
Publications
0 total
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing
Cited by 0
Semantic Scholar
Abstract P4-05-29: ctDNA and serum thymidine kinase activity as tools to stratify ER+/HER2- metastatic breast cancer patients treated with endocrine therapy and CDK4/6 inhibitors: preliminary results of the TIRESIAS trial
Cited by 0
Semantic Scholar
CDK4/6 Inhibitor Resistance in ER+ Breast Cancer.
Cited by 2
Semantic Scholar
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines
Cited by 2
Semantic Scholar
Abstract P1-03-20: Role of MCM2 and the licensing complex in predicting endocrine and CDK4/6 inhibitor resistance in ER+ breast cancer
Cited by 0
Semantic Scholar
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer
Cited by 4
Semantic Scholar
Abstract PO3-13-02: Genomic and intrinsic subtype correlates of serum thymidine kinase activity in patients with metastatic breast cancer treated with palbociclib and fulvestrant in the PYTHIA trial
Cited by 0
Semantic Scholar
Sensitive tumor detection, accurate quantification, and cancer subtype classification using low-pass whole methylome sequencing of plasma DNA OA
Cited by 1
Semantic Scholar
Research Topics
Advanced Breast Cancer Therapies
(90)
Estrogen and related hormone effects
(42)
HER2/EGFR in Cancer Research
(39)
Cancer-related Molecular Pathways
(31)
Lung Cancer Research Studies
(25)
Affiliations
AstraZeneca (United Kingdom)
Brigham and Women's Hospital
University of Udine
Albert Einstein College of Medicine
Translational Research Institute